Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Myeloid Leukemia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03862157
What this trial is testing

Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Eosinophilic Leukemia, Not Otherwise Specified+13 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00003239
What this trial is testing

Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 90
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00219752
What this trial is testing

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years

Who this might be right for
Chronic Myeloid Leukemia
Poitiers University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02480608
What this trial is testing

Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004)

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
University of Leipzig 113
Not applicableStudy completedNCT01805843
What this trial is testing

Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Medical University of Graz 16
Early research (Phase 1)Ended earlyNCT00100152
What this trial is testing

A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)

Who this might be right for
Leukemia, Lymphoblastic, Acute, T-cellMyelogenous LeukemiaChronic Lymphocytic Leukemia+1 more
Merck Sharp & Dohme LLC 50
Large-scale testing (Phase 3)UnknownNCT03942094
What this trial is testing

Nilotinib for First-line Newly Diagnosed CML-CP Patients

Who this might be right for
Chronic Myeloid Leukemia, Chronic PhaseNilotinib
Shenzhen Second People's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00056966
What this trial is testing

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

Who this might be right for
Hematologic Malignancy
Baylor College of Medicine 24
Large-scale testing (Phase 3)Study completedNCT00002456
What this trial is testing

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT03090477
What this trial is testing

Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMedication Adherence
UCSI University 129
Testing effectiveness (Phase 2)Study completedNCT01101880
What this trial is testing

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+8 more
University of Washington 50
Testing effectiveness (Phase 2)Ended earlyNCT00522990
What this trial is testing

Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+2 more
Astex Pharmaceuticals, Inc. 48
Not applicableStudy completedNCT07374120
What this trial is testing

Treatment Patterns and Key Endpoints Among Patients With Chronic-Phase Chronic Myeloid Leukemia in a Community Oncology Setting

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
Novartis Pharmaceuticals 1,480
Testing effectiveness (Phase 2)Active Not RecruitingNCT04233346
What this trial is testing

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Otsuka Beijing Research Institute 93
Not applicableLooking for participantsNCT05682924
What this trial is testing

Condition Vasoregulation Function Endothelium in Patients With CML Getting TKI II Generation Bosutinib

Who this might be right for
Chronic Myeloid Leukaemia
Samara State Medical University 105
Very early researchUnknownNCT03795779
What this trial is testing

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes+2 more
iCell Gene Therapeutics 20
Large-scale testing (Phase 3)UnknownNCT00327262
What this trial is testing

Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
Central European Leukemia Study Group 240
Early research (Phase 1)Looking for participantsNCT03630991
What this trial is testing

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+15 more
M.D. Anderson Cancer Center 58
Post-approval studies (Phase 4)Study completedNCT01660906
What this trial is testing

Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Bristol-Myers Squibb 39
Next Page